Nykode Therapeutics ASA
OSE:NYKD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Nykode Therapeutics ASA
OSE:NYKD
|
NO |
Intrinsic Value
The intrinsic value of Nykode Therapeutics ASA (NYKD) under the Base Case is 1.252 NOK per share. Compared with the current market price of 3.215 NOK, the stock appears Overvalued by 61% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Nykode Therapeutics ASA Does
Nykode Therapeutics is a biotechnology company that develops DNA-based vaccines and immunotherapy candidates for cancer and infectious diseases. Its main work is to design vaccine programs that train the immune system to recognize specific targets, then move those candidates through research and clinical testing. The company is not a drug seller in the usual sense; it is building a pipeline of experimental medicines around its core vaccine technology.
- Headquarters
- Norway NO
- Employees
- 135
- IPO date
- Jan 27, 2020
Revenue & Expenses Breakdown
Nykode Therapeutics ASA
Earnings Waterfall
Nykode Therapeutics ASA
The intrinsic value for Nykode Therapeutics ASA (NYKD) under the Base Case is 1.252 NOK.
Compared with the current market price of 3.215 NOK, the stock appears Overvalued by 61% .